Search Results

Dr. Randall A. Oyer, ACCC Immediate Past President and co-author of Chapter Two, A View from the Ground: The Changing Landscape of Cancer, addresses the complexity and lack of coordination and cooperation among four major care delivery settings, and how this holds us back from reaching our greatest potential in the war against cancer.

Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves.

Genetic counselors—as members of the cancer care team—can help patients better understand their cancer diagnosis, make informed treatment decisions, and navigate the financial costs of testing.

One serious, unwanted side effect of the COVID-19 pandemic is the potential for substantial consequences for cancer outcomes due to delayed access to cancer diagnosis and treatment. Hear from Dr. Debra Patt, the author of a study which detected a substantial decrease (among American seniors) in cancer screenings, visits, therapy, and surgeries.

In this episode, we talk with an experienced cancer center information technology (IT) professional about how the role of the IT professional in quality, patient-centered cancer care delivery and what lies ahead.

We'll discuss the telehealth regulatory and policy changes enacted during the COVID-19 pandemic, what may change in 2021, and what’s likely to remain the same regarding the reimbursement of remote care.

Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.

On this episode of CANCER BUZZ, we discuss how healthcare providers and policymakers can work together to pave the future of telehealth beyond the current public health emergency.